AbbVie Inc. against Teva Pharmaceutical Industries Limited — live side-by-side technical comparison.
Prices as of 2026-09-23T20:03:50+00:00 UTC · updates daily
TEVA leads 4 of the 5 windows we measure — over 1 month ABBV is +0.2% and TEVA +5.6%; over year to date ABBV is +16.0% and TEVA +25.0%. The ABBV/TEVA price ratio stands at 6.7952, below its 50-day average of 7.2003, and below the 200-day average of 6.9263. A ratio above its own average means ABBV is gaining on TEVA; on this reading the recent edge belongs to TEVA.
| ABBV | TEVA | |
|---|---|---|
| Price | $265.08 | $39.01 |
| 1 day | -0.1%lead | -1.3% |
| 5 days | +1.0% | +1.2%lead |
| 1 month | +0.2% | +5.6%lead |
| 6 months | +29.4% | +35.6%lead |
| Year to date | +16.0% | +25.0%lead |
| 52-week position | 95% of range | 92% of range |
| 52-week range | $190.75–$269.39 | $18.21–$40.79 |
| vs 50-day average | above $256.43 | above $35.79 |
| vs 200-day average | above $230.16 | above $33.32 |
| RSI (14) | 55 | 59 |
| Next earnings | 2026-10-29 | 2026-11-04 |
ABBV trades at $265.08, above its 50-day average of $256.43, and above the 200-day at $230.16. It sits at 95% of its 52-week range ($190.75–$269.39); 14-day RSI is 55, in neutral territory; an average session moves it about 2.1%. For levels, the first level overhead is $265.97 (0.3% away) and the first support below is $262.28 (1.1% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.
TEVA trades at $39.01, above its 50-day average of $35.79, and above the 200-day at $33.32. It sits at 92% of its 52-week range ($18.21–$40.79); 14-day RSI is 59, in neutral territory; an average session moves it about 3.3%. For levels, the first level overhead is $40.00 (2.5% away) and the first support below is $35.79 (8.2% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.
TEVA is the more volatile of the two — an average session moves it 3.3% against 2.1% for ABBV, so an identical position size carries roughly 1.6× the daily risk.
The comparison turns on those levels: ABBV clearing $265.97 or losing $262.28; TEVA clearing $40.00 or losing $35.79. Until one of them gives way, the relative reading above stands.